Until recently, sponsors and CROs engaged their central laboratory simply for routine safety
testing. However, as clinical trial protocols have grown in complexity, expert consultation in
diagnostic testing at the beginning of protocol development is fast becoming critical to optimize
test selection and match clinical diagnostic endpoints to outcomes.
This e-book explores how collaborating with your central lab partner early in protocol
development can help optimize clinical trials, drive efficiencies, avoid potential protocol
amendments, and minimize costly study delays.
At ACM Global Central Laboratory, we call this approach Smarter Testing.
